Skip to Main Content

Author Details

Theodora Hatziioannou
The Rockefeller University
1995
127
53
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36473496Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination.Nature2023
37625266Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIV.EBioMedicine2023
38096415Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies.Proc Natl Acad Sci U S A2023
37563124SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates.Nat Commun2023
36952347Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain.Cell Rep2023
37425700SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity.bioRxiv2023
37188812Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies.Nat Microbiol2023
37368240Memory B cell development elicited by mRNA booster vaccinations in the elderly.J Exp Med2023
36653360Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape.Nat Commun2023
35194607Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose.bioRxiv2022
35776090Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans.J Exp Med2022
35735743Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population.mBio2022
35796685Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants.J Exp Med2022
35636436Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis.Lancet Microbe2022
35818364Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection.Open Forum Infect Dis2022
35358263Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting.PLoS One2022
35447092Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins.Immunity2022
35447027Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost.Nature2022
36149398Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans.J Exp Med2022
35982682Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination.medRxiv2022
36052368Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain.bioRxiv2022
36006380Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens.J Exp Med2022
35132412Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins.bioRxiv2022
35030645Plasma Neutralization of the SARS-CoV-2 Omicron Variant.N Engl J Med2022
35169812Antibody and memory B-cell immunity in a heterogeneously SARS-CoV-2 infected and vaccinated population.medRxiv2022
33173867Evolution of Antibody Immunity to SARS-CoV-2.bioRxiv2021
33882219Vaccine Breakthrough Infections with SARS-CoV-2 Variants.N Engl J Med2021
33767445Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.Nature2021
33851164Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.bioRxiv2021
33567448mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.Nature2021
33758864Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies.bioRxiv2021
33758856Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies.bioRxiv2021
33501451mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.bioRxiv2021
33501434Bispecific antibody neutralizes circulating SARS-CoV-2 variants, prevents escape and protects mice from disease.bioRxiv2021
33688659Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants.bioRxiv2021
34936878Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.Cell Rep2021
34874007Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.Elife2021
34931199Plasma neutralization properties of the SARS-CoV-2 Omicron variant.medRxiv2021
35262014Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland.J Clin Virol Plus2021
34648371Replication and single-cycle delivery of SARS-CoV-2 replicons.Science2021
34544114High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.Nature2021
34716452Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.Nat Immunol2021
34534459Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.Cell Rep2021
34619745Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination.Nature2021
34126625Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.Nature2021
34100013Naturally enhanced neutralizing breadth to SARS-CoV-2 after one year.bioRxiv2021
34098567Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.Nature2021
34345019Publisher Correction: Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.Nature2021
34268524Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity.medRxiv2021
34234131Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.Nat Commun2021
  • 1 - 50 of 127

Recommended Authors

Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 4
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Institut Pasteur, CNRS UMR 3569
Career Start Year 2009
Number of shared co-authors 1
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 2008
Number of shared co-authors 6
The Institute of Medical Science, The University of Tokyo
Career Start Year 2008
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 1
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 2
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year 2003
Number of shared co-authors 6
Albert Einstein College of Medicine
Career Start Year 2002
Number of shared co-authors 1
Texas Biomedical Research Institute
Career Start Year 2002
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 10
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 6
University of Washington
Career Start Year 1995
Number of shared co-authors 4
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 3
University of Utah
Career Start Year 1991
Number of shared co-authors 1
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 4
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 1
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 7
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 5
Profectus BioSciences Inc.
Career Start Year 1981
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 2
University of California San Diego, USA VA San Diego Healthcare System
Career Start Year 1978
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1975
Number of shared co-authors 4
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 1
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 7
Center for Family Health Research Zambia
Career Start Year 1971
Number of shared co-authors 4
University of Texas San Antonio
Career Start Year 1971
Number of shared co-authors 3

Collaborators

The Rockefeller University
Co-authored papers 113
The Rockefeller University
Co-authored papers 52
Rockefeller University
Co-authored papers 27
The Rockefeller University
Co-authored papers 22
Co-authored papers 18
Rockefeller University
Co-authored papers 16
The Rockefeller University
Co-authored papers 12
Frederick National Laboratory
Co-authored papers 10
Co-authored papers 7
Columbia University
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 5
The Rockefeller University
Co-authored papers 3
Co-authored papers 3
German Center for Diabetes Research (DZD)
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Center for Global Infectious Disease Research, Seattle Children's Hospital
Co-authored papers 2
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers 2
Co-authored papers 2
The Rockefeller University
Co-authored papers 2
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Co-authored papers 2
The Rockefeller University
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University of California San Francisco
Co-authored papers 2